Stock listing

Cytek Biosciences, Inc.

Selected listing: 8EQ · FWB · EUR · DE

Cytek Biosciences, Inc. (Frankfurt:8EQ), Health Technology. Latest release Sep 23, 2026: Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital…

8EQ:FWBEURDEUpdated September 25, 2026

Ticker: Frankfurt:8EQ
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Frankfurt
Currency: EUR

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (ticker: CTKB) is a public company based in the United States, specializing in advanced cell analysis technologies. The company's products enhance the understanding of complex biological systems, supporting advancements in various fields, including immunology and cancer research.

Latest news from Cytek Biosciences, Inc.

Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool

September 23, 2026

Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS

September 3, 2026

Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding

August 21, 2026

Cytek Biosciences Reports Second Quarter 2026 Financial Results

August 5, 2026

Cytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026

All Cytek Biosciences, Inc. news →

Events

Replays

Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 04:30 PM ET
Watch
Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 04:30 PM ET
Watch

Research Cytek Biosciences, Inc.

Cytek Biosciences, Inc. company profile

View the public company page for Cytek Biosciences, Inc. on 6ix.

Cytek Biosciences, Inc. news

Read company news and market updates connected to Cytek Biosciences, Inc..

Cytek Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Cytek Biosciences, Inc..